Liver Diseases

Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E, Pera G, Grgurevic I, Caballeria L, Piano S, van Kleef L, Reichert M, Roulot D, Pericas JM, Schattenberg JM, Tsochatztis EA, Guha IN, Garcia-Retortillo M, Hernandez R, Hoyo J, Fuentes M, Exposito C, Martinez A, Such P, Madir A, Detlefsen S, Tonon M, Martini A, Ma AT, Pich J, Bonfill E, Juan M, Soria A, Carol M, Gratacos-Gines J, Morillas RM, Toran P, Navarrete JM, Torrejon A, Fournier C, Llorca A, Arslanow A, de Koning HJ, Cucchietti F, Manns M, Newsome PN, Hernaez R, Allen A, Angeli P, de Knegt RJ, Karlsen TH, Galle P, Wong VW, Fabrellas N, Castera L, Krag A, Lammert F, Kamath PS, Gines P, Alvarez M, Andersen P, Angeli P, Ardevol A, Arslanow A, Beggiato L, Ben Abdesselam Z, Bennett L, Boutouria B, Brocca A, Broquetas MT, Caballeria L, Calvino V, Camacho J, Capdevila A, Carol M, Castera L, Cervera M, Cucchietti F, de Fuentes A, de Knegt R, de Koning HJ, Detlefsen S, Diaz A, Dieguez Bande J, Esnault V, Fabrellas N, Falco JL, Fernandez R, Fournier C, Fuentes M, Galle P, Garcia E, Garcia-Retortillo M, Garrido E, Gines P, LiverScreen Consortium Investigators.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
Lancet. 2023 Aug 9:S0140-6736(23)01174-1
DOI: 10.1016/S0140-6736(23)01174-1
IF: 168.90

Pericas JM, Tacke F, Anstee QM, Di Prospero NA, Skalshoj Kjaer M, Mesenbrink P, Koenig F, Genesca J, Ratziu V, Di Prospero NA, Ratziu V, Pericas JM, Skalshoj Kjaer M, Anstee QM, Tacke F, Mesenbrinck P, Rivera-Esteban J, Koenig F, Sena E, Manzano R, Genesca J, Pais R, Kara L, Meyer E, Duca A, Kline T, Aaes-Jorgensen A, Balthaus T, de Preville N, Zhang L, Capuano G, Morello S, Mielke T, Hernandez Penna S, Posch M
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons
J Hepatol. 2023 Feb;78(2):442-447
DOI: 10.1016/j.jhep.2022.09.021
IF: 25.7

Retat L, Webber L, Jepsen P, Martin A, Pinto HC, Lazarus JV, Negro F, Mitchyn M, Guzek J, Card-Gowers J, Graff H, Nahon P, Sheron N, Sagi SZ, Buti M
Preventing liver disease with policy measures to tackle alcohol consumption and obesity: the HEPAHEALTH II study
J Hepatol. 2023 Dec 2:S0168-8278(23)05297-2
DOI: 10.1016/j.jhep.2023.11.021
IF: 25.7

Riveiro-Barciela M, Barreira-Diaz A, Callejo-Perez A, Munoz-Couselo E, Diaz-Mejia N, Diaz-Gonzalez A, Londono MC, Salcedo MT, Buti M
Retreatment with Checkpoint inhibitors after a severe immune-related hepatitis: Results from a prospective multicenter study
Clin Gastroenterol Hepatol. 2023 Mar;21(3):732-740
DOI: 10.1016/j.cgh.2022.03.050
IF: 12.6

Pons M, Esteban JR, Ma MM, Davyduke T, Delamarre A, Hermabessiere P, Dupuy J, Lai-Hung Wong G, Cheuk-Fung Yip T, Pennisi G, Tulone A, Camma C, Petta S, de Ledinghen V, Wai-Sun Wong V, Augustin S, Pericas JM, Abraldes JG, Genesca J
Point-of-care non-invasive prediction of liver-related events in patients with NAFLD
Clin Gastroenterol Hepatol. 2023 Aug 11:S1542-3565(23)00626-2
DOI: 10.1016/j.cgh.2023.08.004
IF: 12.6